Cargando…
Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer
We have investigated dihydropyrimidine dehydrogenase expression as a prognostic marker in breast cancer. A total of 119 women with breast cancer undergoing surgery between 1985 and 1996 were included in this study. Eighty-seven patients were treated with postoperative chemotherapy including 5-fluoro...
Autores principales: | Horiguchi, J, Takei, H, Koibuchi, Y, Iijima, K, Ninomiya, J, Uchida, K, Ochiai, R, Yoshida, M, Yokoe, T, Iino, Y, Morishita, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375185/ https://www.ncbi.nlm.nih.gov/pubmed/11870510 http://dx.doi.org/10.1038/sj.bjc.6600040 |
Ejemplares similares
-
Effects of a dual inhibitor of TNF-α and IL-1 on lipopolysaccharide-induced lung injury in rats
por: Yoshinari, D, et al.
Publicado: (2001) -
Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil
por: Yamada, Y, et al.
Publicado: (2003) -
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours.
por: McLeod, H. L., et al.
Publicado: (1998) -
Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?
por: Vogel, Wendy H., et al.
Publicado: (2020) -
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
por: Ridge, S. A., et al.
Publicado: (1998)